Streamlining biomarker discovery

Nature Biotechnology

Volumn 29, Issue 7, 2011, Pages 600-602

  Latterich, Martin ^a   Schnitzer, Jan E ^a  

^a Proteogenomics Research Institute for Systems Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; PROTEIN BIOMARKER; UNCLASSIFIED DRUG;

ACCURATE INCLUSION MASS SCREENING; BIOINFORMATICS; BLOOD ANALYSIS; DIAGNOSTIC VALUE; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART INFARCTION; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; IMMUNOASSAY; ION TRAP MASS SPECTROMETRY; MASS SPECTROMETER; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEOMICS; SCREENING; SELECTED REACTION MONITORING; SENSITIVITY AND SPECIFICITY; SHORT SURVEY; VALIDATION PROCESS;

ANIMALS; BIOLOGICAL MARKERS; BLOOD CHEMICAL ANALYSIS; HUMANS; MASS SPECTROMETRY; MYOCARDIAL INFARCTION; NEOPLASM PROTEINS; NEOPLASMS, EXPERIMENTAL; PEPTIDE MAPPING; PROTEOME; TUMOR MARKERS, BIOLOGICAL;

EID: 79960262137     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt.1917     Document Type: Short Survey

References (13)

1. Weston, A.D. & Hood, L. J. Proteome Res. 3, 179-196 (2004).
2. Whiteaker, J.R. et al. Nat. Biotechnol. 29, 625-634 (2011).
3. Addona, T.A. et al. Nat. Biotechnol. 29, 635-643 (2011).
4. Jaffe, J.D. et al. Mol. Cell. Proteomics 7, 1952-1962 (2008).
5. Ong, S.E. et al. Mol. Cell. Proteomics 1, 376-386 (2002).
6. Wu, W.W. et al. J. Proteome Res. 5, 651-658 (2006).
7. Blonder, J., Issaq, H.J. & Veenstra, T.D. Electrophoresis published online, doi:10.1002/elps.201000585 (9 May 2011).
8. Ray, S. et al. Proteomics 11, 2139-2161 (2011).
9. Lu, B., Xu, T., Park, S.K. & Yates, J.R. Methods Mol. Biol. 564, 261-288 (2009).
10. Griffin, N.M. et al. Nat. Biotechnol. 28, 83-89 (2010).
11. Paweletz, C.P. et al. J. Proteome Res. 9, 1392-1401 (2010).
12. Latterich, M., Abramovitz, M. & Leyland-Jones, B. Eur. J. Cancer 44, 2737-2741 (2008).
13. Denham, J.W. et al. Cancer 115, 4477-4487 (2009).